Cargando…
Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan
BACKGROUND: In Japan, vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was initiated on 17 February 2021, mainly using messenger RNA vaccines and prioritizing health care professionals. Whereas nationwide vaccination alleviated the coronavirus disease 2019 (COVID-19)-...
Autores principales: | Kayano, Taishi, Sasanami, Misaki, Kobayashi, Tetsuro, Ko, Yura K., Otani, Kanako, Suzuki, Motoi, Nishiura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366235/ https://www.ncbi.nlm.nih.gov/pubmed/35971514 http://dx.doi.org/10.1016/j.lanwpc.2022.100571 |
Ejemplares similares
-
Evaluating the COVID-19 vaccination program in Japan, 2021 using the counterfactual reproduction number
por: Kayano, Taishi, et al.
Publicado: (2023) -
Assessing Public Health and Social Measures Against COVID-19 in Japan From March to June 2021
por: Hayashi, Katsuma, et al.
Publicado: (2022) -
Monitoring the COVID-19 immune landscape in Japan
por: Sasanami, Misaki, et al.
Publicado: (2022) -
Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination
por: Sasanami, Misaki, et al.
Publicado: (2023) -
Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan
por: Kayano, Taishi, et al.
Publicado: (2022)